As more rare disease therapies launch, their prices are rising

seekingalpha04-17

Therapies that treat rare diseases are among the most expensive treatments for patients, with price tags often reaching seven figures. Despite their high price, the treatments are usually lucrative ...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2428877320?lang=en_US&edition=fundamental","thumbnail":"https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1489211062/image_1489211062.jpg","is_english":true,"pubTime":"2024-04-17 00:22","share_image_url":"https://static.laohu8.com/5a36db9d73b4222bc376d24ccc48c8a4","id":"2428877320","market":"hk","top_or_hot":-1,"title":"As more rare disease therapies launch, their prices are rising","media":"seekingalpha","content":"<div>\n<p>Therapies that treat rare diseases are among the most expensive treatments for patients, with price tags often reaching seven figures. Despite their high price, the treatments are usually lucrative ...</p>\n\n<a href=\"https://seekingalpha.com/news/4089415-more-rare-disease-therapies-launch-their-prices-rising\">Source Link</a>\n\n</div>\n","source":"seekingalpha","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>As more rare disease therapies launch, their prices are rising</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAs more rare disease therapies launch, their prices are rising\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-04-17 00:22 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://seekingalpha.com/news/4089415-more-rare-disease-therapies-launch-their-prices-rising><strong>seekingalpha</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Therapies that treat rare diseases are among the most expensive treatments for patients, with price tags often reaching seven figures. Despite their high price, the treatments are usually lucrative ...</p>\n\n<a href=\"https://seekingalpha.com/news/4089415-more-rare-disease-therapies-launch-their-prices-rising\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"RARE","symbol_name":"Ultragenyx Pharmaceutical Inc","start_time":0,"source_url":"https://seekingalpha.com/news/4089415-more-rare-disease-therapies-launch-their-prices-rising","article_id":"2428877320","we_media_id":null,"thumbnails":["https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1489211062/image_1489211062.jpg"],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2428877320","pubTimestamp":1713284570,"sourceInfo":{"source_id":"seekingalpha","name":"Seeking Alpha"},"weMediaInfo":null,"summary":"Therapies that treat rare diseases are among the most expensive treatments for patients, with price tags often reaching seven figures. Despite their high price, the treatments are usually lucrative fo","collect":0,"end_time":0,"defaultTopTitle":"seekingalpha.com","property":[],"viewcount":null,"language":"en","relate_stocks":{"RARE":"Ultragenyx Pharmaceutical Inc","BMY":"施贵宝","03165":"华夏欧优股对冲","LU2242652126.USD":"FIDELITY FUNDS GLOBAL DIVIDENDS PLUS \"A\" (USD) INC","LU0114720955.EUR":"SUSTAINABLE GLOBAL HEALTH CARE \"A\" INC","SG9999003800.SGD":"Nikko AM Global Dividend Equity Acc SGD-H","RHHBY":"罗氏控股","LU2491049909.HKD":"WELLINGTON SUSTAINABLE OUTCOMES \"A\" (HKD) ACC","SG9999014559.SGD":"United Income Focus Trust Dis SGD","SQQQ":"纳指三倍做空ETF","LU2491050071.SGD":"WELLINGTON SUSTAINABLE OUTCOMES \"A\" (SGDHDG) ACC",".IXIC":"NASDAQ Composite","LU2491050154.USD":"WELLINGTON SUSTAINABLE OUTCOMES \"A\" (USD) ACC","LU2237443382.USD":"Aberdeen Standard SICAV I - Global Dynamic Dividend A MIncA USD","IE0009355771.USD":"骏利亨德森环球生命科技A Acc","LU1551013342.USD":"Allianz Income and Growth Cl AMg2 DIS USD","PFE.AU":"PANTERA MINERALS LTD","LU2461242641.AUD":"WELLINGTON US QUALITY GROWTH \"A\" (AUDHDG) ACC","LU1670710588.SGD":"M&G (LUX) GLOBAL DIVIDEND \"A\" (SGD) ACC","GB00BDT5M118.USD":"天利环球扩展Alpha基金A Acc","LLY":"礼来","LU2237443549.SGD":"Aberdeen Standard SICAV I - Global Dynamic Dividend A MIncA SGD-H","LU2237443622.USD":"Aberdeen Standard SICAV I - Global Dynamic Dividend A Acc USD","FOLD":"爱美医疗","LU1670710661.SGD":"M&G (LUX) GLOBAL DIVIDEND \"A\" (SGD) INC","SG9999011175.SGD":"Nikko AM Global Dividend Equity Dis SGD-H","LU2237443978.SGD":"Aberdeen Standard SICAV I - Global Dynamic Dividend A Acc SGD-H","LU2065170008.USD":"M&G (LUX) GLOBAL MAXIMA \"A\" (USD) INC","SG9999014575.USD":"UOB UNITED INCOME FOCUS TRUST FUND (USDHDG) INC","LU1804176565.USD":"EASTSPRING INV GLOBAL GROWTH EQUITY \"A\" (USD) ACC","BK4566":"资本集团","MRK":"默沙东","BK4007":"制药","AMGN":"安进","QID":"纳指两倍做空ETF","BIIB":"渤健公司","INBX":"Inhibrx, Inc.","TVTX":"Travere Therapeutics, Inc.","LU0097036916.USD":"贝莱德美国增长A2 USD","LU0882574055.USD":"富达全球健康医疗A ACC","TQQQ":"纳指三倍做多ETF","PFE":"辉瑞","BK7095":"多种金属与采矿","SRPT":"Sarepta Therapeutics","ARCT":"Arcturus Therapeutics Ltd.","PSQ":"纳指反向ETF","QQQ":"纳指100ETF","QLD":"纳指两倍做多ETF"},"translate_title":"随着更多罕见疾病疗法的推出，它们的价格也在上涨","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"TVTX":1,"MRK":1,"PFE":1,"PFE.AU":1,"RARE":1,"RHHBY":1,"LLY":1,"INBX":1,"FOLD":1,"SRPT":1,"AMGN":1,"BIIB":1,"ARCT":1,"BMY":1,".IXIC":0.9,"QLD":0.6,"PSQ":0.6,"QID":0.6,"QQQ":0.6,"TQQQ":0.6,"SQQQ":0.6,"03165":0.6,"MNQmain":0.6,"NQmain":0.6},"content_text":"Therapies that treat rare diseases are among the most expensive treatments for patients, with price tags often reaching seven figures. Despite their high price, the treatments are usually lucrative for the pharma and biotechs that market them given they may be the only drug option for a patient and could potentially be lifesaving. The enormous cost is a result of the relatively small population -- sometimes less than 10,000 patients -- many rare disease therapies treat. Pharmas and biotechs need to recoup the immense R&D costs that go into bringing a new therapy to market -- and also make a profit. Research indicates that treatments for rare disease conditions related to metabolism, immunology, and hepatology are the most expensive.  The most expensive medicine in the world, Lenmeldy (atidarsagene autotemcel), was just approved in March and comes with a wholesale price of $4.25M. The gene therapy from Orchard Therapeutics (recently acquired by Japanese pharma Kyowa Kirin), given just once, treats metachromatic leukodystrophy. About 40 children in the U.S. each year are born with the genetic disorder. A new analysis from Cantor Fitzgerald found that the already sky high prices of rare disease treatments have been increasing since 2021. Therapies that benefit less than 10,000 patients have a mean cost of ~$3.2M. The figure for rare disease therapies helping more than 10,000 patients is ~$2M.  The analysis noted that since prices, especially for one-time gene therapies, have been rising year-over-year, \"investors should consider what other gene therapies have recently priced at and assume a higher level than previous years.\" The investment firm also notes that rare disease medications that are considered chronic therapies -- given more than once -- can easily cost $500,000 or more per year. This is mostly the case if the patient population is less than 1,000. In addition, pricing is negatively impacted if there is competition for a therapy.  Cantor Fitzgerald also noted that a rare disease condition's lethality also influences its price. \"Childhood lethal indications could support annual pricing of ~$600K+ (potentially $1M+), and pricing for adult lethal indications could be ~two-thirds the price of childhood lethal indications.\" Selected pharmas and biotechs focused on rare diseases: Ultragenyx Pharamceuticals (NASDAQ:RARE), Sarepta Therapeutics (NASDAQ:SRPT), Inhibrx (NASDAQ:INBX), Arcturus Therapeutics (NASDAQ:ARCT), Amicus Therapeutics (FOLD), Tand ravere Therapeutics (TVTX). Selected large pharmas and biotech with rare disease assets: Merck (MRK), Pfizer (PFE), Eli Lilly (LLY), Bristol-Myers Squibb (BMY), Roche (OTCQX:RHHBY), Biogen (BIIB), and Amgen (AMGN).  More on rare disease pharmas/biotechs  Sarepta Therapeutics: Growth Trajectory Alters Trading Strategy Sarepta Therapeutics: Another 'Hold' Call Ahead Of Some Key Catalysts Ultragenyx Pharmaceutical Earnings: No Visible Path To Financial Success Yet Arcturus Therapeutics Q4 2023 Earnings Preview Sarepta Therapeutics Q4 2023 Earnings Preview","kind":null,"is_publish_news":null,"is_publish_highlight":null,"is_publish_live":null,"is_publish_wemedia":null,"editions":null,"symbols":[],"gpt_button":1},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.22.4","shortVersion":"4.22.4","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2428877320"}